Advertisement
Canada markets closed
  • S&P/TSX

    21,698.11
    -263.44 (-1.20%)
     
  • S&P 500

    5,433.74
    +12.71 (+0.23%)
     
  • DOW

    38,647.10
    -65.11 (-0.17%)
     
  • CAD/USD

    0.7277
    -0.0012 (-0.16%)
     
  • CRUDE OIL

    77.95
    -0.55 (-0.70%)
     
  • Bitcoin CAD

    91,541.30
    -1,552.20 (-1.67%)
     
  • CMC Crypto 200

    1,419.01
    +6.05 (+0.43%)
     
  • GOLD FUTURES

    2,318.90
    -35.90 (-1.52%)
     
  • RUSSELL 2000

    2,038.91
    -18.19 (-0.88%)
     
  • 10-Yr Bond

    4.2380
    -0.0570 (-1.33%)
     
  • NASDAQ

    17,667.56
    +59.12 (+0.34%)
     
  • VOLATILITY

    11.96
    -0.08 (-0.67%)
     
  • FTSE

    8,163.67
    -51.81 (-0.63%)
     
  • NIKKEI 225

    38,720.47
    -156.24 (-0.40%)
     
  • CAD/EUR

    0.6772
    +0.0033 (+0.49%)
     

Is This the Telltale Sign to Sell Novavax Stock?

Is This the Telltale Sign to Sell Novavax Stock?

Unfortunately, Novavax (NASDAQ: NVAX) hasn't had great timing. The company was late to the party in winning authorizations for its COVID-19 vaccine, Nuvaxovid. If you only looked at Novavax's press releases, you wouldn't know about some recent bad news for the company.